Table 2.
Severity of infection | ||||
---|---|---|---|---|
Number of infection events (n = 47) | Number of patients (n = 55) | |||
Any severity* | High severity† | Any severity* | High severity† | |
Any infection, n (%) | 47 (100) | 4 (9) | 29 (53) | 3 (6) |
Bacterial infections, n (%) | 19 (40) | 3 (6) | 15 (27) | 3 (6) |
Bacterial site,‡ n (%) | 14 (30) | 2 | 12 (22) | 2 (4) |
Gram-positive bacteremia, n (%) | 2 (4) | 0 (0) | 2 (4) | 0 (0) |
Gram-negative bacteremia, n (%) | 3 (6) | 1 (2) | 3 (6) | 2 (4) |
Viral infections, n (%) | 25 (53) | 0 (0) | 18 (33) | 2 (4) |
Respiratory virus, n (%) | 25 (53) | 0 (0) | 18 (33) | 2 (4) |
Other, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Fungal infection, n (%) | 3 (6) | 1 (2) | 3 (6) | 1 (2) |
Mold fungal, n (%) | 2 (4) | 1 (2) | 2 (4) | 1 (2) |
Nonmold fungal, n (%) | 1 (2) | 0 (0) | 1 (2) | 0 (0) |
Organ system | ||||
Lower respiratory, n (%) | 16 (34) | 0 (0) | 14 (30) | 2 (4) |
Upper respiratory, n (%) | 16 (34) | 0 (0) | 14 (30) | 2 (4) |
Bloodstream, n (%) | 1 (2) | 1 (2) | 1 (2) | 1 (2) |
GI, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
CNS, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Other,§ n (%) | 14 (30) | 3 (6) | 9 (16) | 2 (4) |
CNS, central nervous system; GI, gastrointestinal.
Any severity: infections that are mild, moderate, severe, life-threatening, or fatal.
High severity: infections that are severe, life-threatening, or fatal.
Site-specific bacterial infections were defined as evidence of bacterial infection by culture of a normally sterile site or by culture and evidence of tissue invasion of a nonsterile site.
Other includes skin and urinary tract, among other infections.